According to FutureWise analysis the market for tetanus in 2023 is US$ 1.57 billion, and is expected to reach US$ 2.23 billion by 2031 at a CAGR of 4.50%.
Tetanus, also known as lockjaw, occurs when the bacterium clostridium tetani spreads into the environment, particularly when soils are moist and warm. The condition is characterized by convulsive spasms and generalized rigidity of skeletal muscles. The stiffness of the muscles first appears in the jaw and neck area before becoming generalized. The use of formaldehyde to inactivate tetanus was introduced in the early 1920s by Ramon and led directly to the development of tetanus toxoids in 1924. There is a considerable public health risk associated with tetanus following injuries in children and adults. The mortality rate of tetanus is 100% if it is not treated. The infection can be treated with vaccinations and various medications.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Tetanus Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Tetanus Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.